Dovitinib lactate hydrate
Cat.No:ID7740 Solarbio
CAS:915769-50-5
Molecular Formula:C24H29FN6O5
Molecular Weight:500.52
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Dovitinib lactate hydrateCAS:915769-50-5
Molecular Formula:C24H29FN6O5
Molecular Weight:500.52
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Solid
Qty:
Size:
CAS | 915769-50-5 |
Name | Dovitinib lactate hydrate |
Molecular Formula | C24H29FN6O5 |
Molecular Weight | 500.52 |
Solubility | Soluble in DMSO ≥10mg/mL |
Purity | ≥98% |
Appearance | Solid |
Storage | Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
Target Point | Tyrosine Kinase |
Passage | Protein Tyrosine Kinase/RTK |
Background | Dovitinib lactate hydrate is a multi-target tyrosine kinase inhibitor that inhibits FLT3, c-Kit, FGFR1/3, VEGFR1/2/3 and PDGFRα/β. |
Unit | Bottle |
Specification | 1mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.